EXACT Sciences Ownership
| EXAS Stock | USD 101.45 0.32 0.32% |
Shares in Circulation | First Issued 2001-03-31 | Previous Quarter 188.9 M | Current Value 189.3 M | Avarage Shares Outstanding 84.3 M | Quarterly Volatility 60.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. EXACT Stock Ownership Analysis
About 95.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 5.36. EXACT Sciences had not issued any dividends in recent years. Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people. To learn more about EXACT Sciences call Kevin Conroy at 608 284 5700 or check out https://www.exactsciences.com.Besides selling stocks to institutional investors, EXACT Sciences also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different EXACT Sciences' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align EXACT Sciences' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
EXACT Sciences Quarterly Liabilities And Stockholders Equity |
|
EXACT Sciences Insider Trades History
Less than 1% of EXACT Sciences are currently held by insiders. Unlike EXACT Sciences' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against EXACT Sciences' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of EXACT Sciences' insider trades
EXACT Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as EXACT Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading EXACT Sciences backward and forwards among themselves. EXACT Sciences' institutional investor refers to the entity that pools money to purchase EXACT Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ameriprise Financial Inc | 2025-06-30 | 2.2 M | Goldman Sachs Group Inc | 2025-06-30 | 2.2 M | Millennium Management Llc | 2025-06-30 | 2.2 M | Holocene Advisors, Lp | 2025-06-30 | 2.1 M | William Blair Investment Management, Llc | 2025-06-30 | 2 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 1.9 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 1.9 M | Bamco Inc | 2025-06-30 | 1.9 M | Aqr Capital Management Llc | 2025-06-30 | 1.8 M | Fmr Inc | 2025-06-30 | 26.9 M | Capital World Investors | 2025-06-30 | 18.2 M |
EXACT Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EXACT Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on EXACT Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EXACT Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
EXACT Sciences' latest congressional trading
Congressional trading in companies like EXACT Sciences, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in EXACT Sciences by those in governmental positions are based on the same information available to the general public.
| 2020-11-20 | Representative Jim Hagedorn | Acquired Under $15K | Verify |
EXACT Sciences Outstanding Bonds
EXACT Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. EXACT Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EXACT bonds can be classified according to their maturity, which is the date when EXACT Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US30063PAB13 Corp BondUS30063PAB13 | View | |
| US30063PAC95 Corp BondUS30063PAC95 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
EXACT Sciences Corporate Filings
| 26th of November 2025 Other Reports | ViewVerify | |
F4 | 21st of November 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 20th of November 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of November 2025 Other Reports | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.